[Efficacious treatment of a fatal blood disease: polycythemia vera].
Sánchez Fayos
J
J
Servicio de Hematología y Hemoterapia, Fundación Jiménez Díaz, Facultad de Medicina, Universidad Autónoma, Madrid.
Román Barbero
A
A
Nevado Reviriego
I
I
D000208:Acute Disease; D000477:Alkylating Agents / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D002699:Chlorambucil / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000139:chemically induced / Q000453:epidemiology; D007953:Leukemia, Radiation-Induced / Q000139:chemically induced / Q000453:epidemiology; D018962:Phlebotomy; D010761:Phosphorus Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D010885:Pipobroman / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D000477:Alkylating Agents; D010761:Phosphorus Radioisotopes; D010975:Platelet Aggregation Inhibitors; D002699:Chlorambucil; D010885:Pipobroman; D002066:Busulfan; D006918:Hydroxyurea